SELENA ROGGEVEEN: Open Payments
NPI 1134993041 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $91 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $30 |
| Tris Pharma Inc | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: ZORYVE, OTEZLA, Dyanavel XR, LINZESS, FREESTYLE LIBRE 3, NEFFY, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
